Page last updated: 2024-09-02

zacopride and Glioma

zacopride has been researched along with Glioma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bryce, D; Chalabi, PM; Furman, J; Guarino, KJ; Ives, JL; McLean, S; Nagel, AA; Rosen, T; Roth, RW; Seeger, TF1
Emerit, MB; Fattaccini, CM; Hamon, M; Riad, M1
Gozlan, H; Hamon, M; Kidd, FJ; Levy, JC; Nielsen, M1
Barnes, JM; Barnes, NM1
Nishida, A; Shimizu, M; Yamawaki, S; Zensho, H1
BolaƱos, FJ; Emerit, MB; Gozlan, H; Hamon, M; Miquel, MC; Schechter, LE1

Other Studies

6 other study(ies) available for zacopride and Glioma

ArticleYear
Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:11

    Topics: Animals; Blood-Brain Barrier; Brain; Chemical Phenomena; Chemistry; Glioma; Imidazoles; Mice; Molecular Structure; Neuroblastoma; Serotonin Antagonists; Thiazoles; Tumor Cells, Cultured

1990
Characteristics of [14C]guanidinium accumulation in NG 108-15 cells exposed to serotonin 5-HT3 receptor ligands and substance P.
    Journal of neurochemistry, 1993, Volume: 60, Issue:6

    Topics: Animals; Benzamides; Biological Transport; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carbon Radioisotopes; Cations; Dose-Response Relationship, Drug; Glioma; Guanidine; Guanidines; Hybrid Cells; Kinetics; Mice; Neuroblastoma; Neuropeptides; Rats; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Substance P; Tumor Cells, Cultured

1993
Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
    European journal of pharmacology, 1993, Sep-15, Volume: 247, Issue:1

    Topics: Aged; Aged, 80 and over; Animals; Benzamides; Binding Sites; Brain; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Female; Glioma; Hippocampus; Humans; Male; Mianserin; Ondansetron; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Spinal Cord; Stereoisomerism; Tissue Distribution; Tumor Cells, Cultured

1993
Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
    Biochemical pharmacology, 1993, May-25, Volume: 45, Issue:10

    Topics: Animals; Benzamides; Biguanides; Binding Sites; Binding, Competitive; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Membrane; Glioma; Granisetron; Indazoles; Kinetics; Neuroblastoma; Ondansetron; Quipazine; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium

1993
Chronic amitriptyline exposure reduces 5-HT3 receptor-mediated cyclic GMP formation in NG 108-15 cells.
    Brain research, 1996, Nov-25, Volume: 741, Issue:1-2

    Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Benzamides; Bradykinin; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cyclic GMP; Fluorescent Dyes; Fura-2; Glioma; Hybrid Cells; Indoles; Kinetics; Neuroblastoma; Receptors, Serotonin; Serotonin Antagonists; Tropisetron; Tumor Cells, Cultured

1996
Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells.
    Journal of neurochemistry, 1990, Volume: 55, Issue:5

    Topics: Animals; Benzamides; Binding Sites; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Membrane; Chemical Phenomena; Chemistry, Physical; Cholic Acids; Detergents; Glioma; Molecular Weight; Neuroblastoma; Receptors, Serotonin; Serotonin Antagonists; Solubility; Tumor Cells, Cultured

1990